Sagimet Biosciences (SGMT) EPS (Weighted Average and Diluted) (2022 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly EPS (Weighted Average and Diluted) of -$0.33 in Q1 2026, down 10.0% quarter-over-quarter from -$0.3 in Q4 2025, and up 41.07% on a YoY basis from -$0.23 in Q1 2025.
Sagimet Biosciences (SGMT) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
Sagimet Biosciences' EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.33 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 41.07% year-over-year to -$0.33; the TTM figure through Mar 2026 stood at -$1.35 (up 23.3% YoY), while the FY2025 annual figure was -$1.58, down 8.97% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.33 for Q1 2026 at Sagimet Biosciences, down from -$0.3 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.56 in Q4 2023 to a low of -$40.34 in Q3 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$12.02 across 5 years, with a median of -$0.43 in 2024.
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) soared 101.43% in 2023, then tumbled 189.29% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$39.07 in 2022, then jumped by 101.43% to $0.56 in 2023, then sank by 189.29% to -$0.5 in 2024, then surged by 40.0% to -$0.3 in 2025, then fell by 10.0% to -$0.33 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.33 (Q1 2026), -$0.3 (Q4 2025), and -$0.4 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -0.32 |
| Mar 31, 2025 | -0.56 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.45 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -35.80 |
| Mar 31, 2023 | -35.58 |
| Dec 31, 2022 | -39.07 |
| Sep 30, 2022 | -40.34 |
| Jun 30, 2022 | -38.37 |